Literature DB >> 33270986

Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis.

Katerina Placek1, Michael Benatar2, Joanne Wuu2, Evadnie Rampersaud3, Laura Hennessy1, Vivianna M Van Deerlin4, Murray Grossman1, David J Irwin1, Lauren Elman1, Leo McCluskey1, Colin Quinn1, Volkan Granit2, Jeffrey M Statland5, Ted M Burns6, John Ravits7, Andrea Swenson8, Jon Katz9, Erik P Pioro10, Carlayne Jackson11, James Caress12, Yuen So13, Samuel Maiser14, David Walk14, Edward B Lee4, John Q Trojanowski4, Philip Cook15, James Gee15, Jin Sha16,17, Adam C Naj4,16,17, Rosa Rademakers18, Wenan Chen3, Gang Wu3, J Paul Taylor3,19, Corey T McMillan1.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a multi-system disease characterized primarily by progressive muscle weakness. Cognitive dysfunction is commonly observed in patients; however, factors influencing risk for cognitive dysfunction remain elusive. Using sparse canonical correlation analysis (sCCA), an unsupervised machine-learning technique, we observed that single nucleotide polymorphisms collectively associate with baseline cognitive performance in a large ALS patient cohort (N = 327) from the multicenter Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium. We demonstrate that a polygenic risk score derived using sCCA relates to longitudinal cognitive decline in the same cohort and also to in vivo cortical thinning in the orbital frontal cortex, anterior cingulate cortex, lateral temporal cortex, premotor cortex, and hippocampus (N = 90) as well as post-mortem motor cortical neuronal loss (N = 87) in independent ALS cohorts from the University of Pennsylvania Integrated Neurodegenerative Disease Biobank. Our findings suggest that common genetic polymorphisms may exert a polygenic contribution to the risk of cortical disease vulnerability and cognitive dysfunction in ALS.
© 2020 The Authors. Published under the terms of the CC BY 4.0 license.

Entities:  

Keywords:  amyotrophic lateral sclerosis; cognition; frontotemporal dementia; machine learning; polygenic score

Mesh:

Year:  2020        PMID: 33270986      PMCID: PMC7799365          DOI: 10.15252/emmm.202012595

Source DB:  PubMed          Journal:  EMBO Mol Med        ISSN: 1757-4676            Impact factor:   14.260


  73 in total

Review 1.  Extensions of sparse canonical correlation analysis with applications to genomic data.

Authors:  Daniela M Witten; Robert J Tibshirani
Journal:  Stat Appl Genet Mol Biol       Date:  2009-06-09

2.  The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

Authors:  J M Cedarbaum; N Stambler; E Malta; C Fuller; D Hilt; B Thurmond; A Nakanishi
Journal:  J Neurol Sci       Date:  1999-10-31       Impact factor: 3.181

3.  N4ITK: improved N3 bias correction.

Authors:  Nicholas J Tustison; Brian B Avants; Philip A Cook; Yuanjie Zheng; Alexander Egan; Paul A Yushkevich; James C Gee
Journal:  IEEE Trans Med Imaging       Date:  2010-04-08       Impact factor: 10.048

4.  Development and validation of pedigree classification criteria for frontotemporal lobar degeneration.

Authors:  Elisabeth M Wood; Dana Falcone; Eunran Suh; David J Irwin; Alice S Chen-Plotkin; Edward B Lee; Sharon X Xie; Vivianna M Van Deerlin; Murray Grossman
Journal:  JAMA Neurol       Date:  2013-11       Impact factor: 18.302

5.  Deep clinical and neuropathological phenotyping of Pick disease.

Authors:  David J Irwin; Johannes Brettschneider; Corey T McMillan; Felicia Cooper; Christopher Olm; Steven E Arnold; Vivianna M Van Deerlin; William W Seeley; Bruce L Miller; Edward B Lee; Virginia M-Y Lee; Murray Grossman; John Q Trojanowski
Journal:  Ann Neurol       Date:  2015-12-25       Impact factor: 10.422

6.  A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank.

Authors:  Jon B Toledo; Vivianna M Van Deerlin; Edward B Lee; EunRan Suh; Young Baek; John L Robinson; Sharon X Xie; Jennifer McBride; Elisabeth M Wood; Theresa Schuck; David J Irwin; Rachel G Gross; Howard Hurtig; Leo McCluskey; Lauren Elman; Jason Karlawish; Gerard Schellenberg; Alice Chen-Plotkin; David Wolk; Murray Grossman; Steven E Arnold; Leslie M Shaw; Virginia M-Y Lee; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2013-08-24       Impact factor: 21.566

7.  Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis.

Authors:  Dorothée Lulé; Sarah Böhm; Hans-Peter Müller; Helena Aho-Özhan; Jürgen Keller; Martin Gorges; Markus Loose; Jochen H Weishaupt; Ingo Uttner; Elmar Pinkhardt; Jan Kassubek; Kelly Del Tredici; Heiko Braak; Sharon Abrahams; Albert C Ludolph
Journal:  Cortex       Date:  2018-01-31       Impact factor: 4.027

8.  Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study.

Authors:  Susan Byrne; Marwa Elamin; Peter Bede; Aleksey Shatunov; Cathal Walsh; Bernie Corr; Mark Heverin; Norah Jordan; Kevin Kenna; Catherine Lynch; Russell L McLaughlin; Parameswaran Mahadeva Iyer; Caoimhe O'Brien; Julie Phukan; Brona Wynne; Arun L Bokde; Daniel G Bradley; Niall Pender; Ammar Al-Chalabi; Orla Hardiman
Journal:  Lancet Neurol       Date:  2012-02-03       Impact factor: 44.182

9.  Analysis of polygenic risk score usage and performance in diverse human populations.

Authors:  L Duncan; H Shen; B Gelaye; J Meijsen; K Ressler; M Feldman; R Peterson; B Domingue
Journal:  Nat Commun       Date:  2019-07-25       Impact factor: 14.919

10.  Screening for cognition and behaviour changes in ALS.

Authors:  Sharon Abrahams; Judith Newton; Elaine Niven; Jennifer Foley; Thomas H Bak
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-06-19       Impact factor: 4.092

View more
  3 in total

1.  Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches.

Authors:  Corey T McMillan; Joanne Wuu; Katya Rascovsky; Stephanie Cosentino; Murray Grossman; Lauren Elman; Colin Quinn; Luis Rosario; Jessica H Stark; Volkan Granit; Hannah Briemberg; Sneha Chenji; Annie Dionne; Angela Genge; Wendy Johnston; Lawrence Korngut; Christen Shoesmith; Lorne Zinman; Sanjay Kalra; Michael Benatar
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2022-03-07       Impact factor: 3.528

2.  Risk score prediction model based on single nucleotide polymorphism for predicting malaria: a machine learning approach.

Authors:  Kah Yee Tai; Jasbir Dhaliwal; KokSheik Wong
Journal:  BMC Bioinformatics       Date:  2022-08-07       Impact factor: 3.307

3.  Deep learning methods may not outperform other machine learning methods on analyzing genomic studies.

Authors:  Yao Dong; Shaoze Zhou; Li Xing; Yumeng Chen; Ziyu Ren; Yongfeng Dong; Xuekui Zhang
Journal:  Front Genet       Date:  2022-09-23       Impact factor: 4.772

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.